TNF-α regulates vascular smooth muscle cell responses in genetic hypertension

International Immunopharmacology

Volumn 9, Issue 7-8, 2009, Pages 837-843

  Lee, Se Jung ^a,c   Kim, Wun Jae ^b,c   Moon, Sung Kwon ^a,c  

^a Chungju National University   (South Korea)

^b Chungbuk National University College of Medicine   (South Korea)

^c Chungbuk National University   (South Korea)

Author keywords

Cell proliferation; Hypertension; SHR; TNF ; VSMC; WKY

Indexed keywords

CYCLIN D1; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 4; CYCLIN E; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN P21; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CELL CYCLE G1 PHASE; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CELL PROLIFERATION; CONTROLLED STUDY; HEREDITARY HYPERTENSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SMOOTH MUSCLE FIBER; UPREGULATION; VASCULAR SMOOTH MUSCLE;

ANIMALS; AORTA; CELL CYCLE PROTEINS; CELL PROLIFERATION; CELL SEPARATION; CELLS, CULTURED; DNA-BINDING PROTEINS; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; HYPERTENSION; MATRIX METALLOPROTEINASE 9; MUTAGENESIS, SITE-DIRECTED; MYOCYTES, SMOOTH MUSCLE; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; RATS; RATS, INBRED WKY; SPECIES SPECIFICITY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 67349104194     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2009.03.010     Document Type: Article

References (32)

1. Intengan H.D., and Schiffrin E.L. Vascular remodeling in hypertension: roles of apoptosis, inflammation, and fibrosis. Hypertension 38 (2001) 581-587
2. Mulvany M.J., Baumbach G.L., Aalkjaer C., Heagerty A.M., Korsgaard N., Schiffrin E.L., et al. Vascular remodeling. Hypertension 28 (1996) 505-506
3. Geisterfer A.A., Peach M.J., and Owens G.K. Angiotensin II induces hypertrophy, not hyperplasia, of cultured rat aortic smooth muscle cells. Circ Res 62 (1998) 749-756
4. Touyz R.M., Deng L.Y., He G., and Schiffrin E.L. Angiotensin II stimulates DNA and protein synthesis in vascular smooth muscle cells from human peripheral resistance arteries: role of extracellular signal-regulated kinases. J Hypertens 17 (1999) 907-917
5. Benetos A., Levy B.I., Lacolley P., Taillard F., Duriez M., and Safar M.E. Role of Ang II and bradykinin on aortic collagen following converting enzyme inhibition in spontaneously hypertensive rats. Arterioscler Thromb Vasc Biol 17 (1997) 3196-3201
6. Tanner F.C., Greutert H., Barandier C., Frischknecht K., and Lüscher T.F. Different cell cycle regulation of vascular smooth muscle in genetic hypertension. Hypertension 42 2 (2003) 184-188
7. Touyz R.M., He G., El Mabrouk M., and Schiffrin E.L. p38 Map kinase regulates vascular smooth muscle cell collagen synthesis by angiotensin II in SHR but not in WKY. Hypertension 37 2 Part 2 (2001) 574-580
8. Agrotis A., Saltis J., and Bobik A. Effect of transforming growth factor-beta 1 on platelet-derived growth factor receptor binding and gene expression in vascular smooth muscle cells from SHR and WKY rats. Clin Exp Pharmacol Physiol 21 2 (1994) 145-148
9. Ebisui O., Dilley R.J., Li H., Funder J.W., and Liu J.P. Growth factors and extracellular signal-regulated kinase in vascular smooth muscle cells of normotensive and spontaneously hypertensive rats. J Hypertens 17 11 (1999) 1535-1541
10. Shinzato T., Ohya Y., Nakamoto M., Ishida A., and Takishita S. Beneficial effects of pioglitazone on left ventricular hypertrophy in genetically hypertensive rats. Hypertens Res 30 9 (2007) 863-873
11. Granger J.P. An emerging role for inflammatory cytokines in hypertension. Am J Physiol Heart Circ Physiol 290 3 (2006) H923-924
12. Lee H.M., Kim H.J., Won K.J., Choi W.S., Lee K.Y., Bae Y.M., et al. Contribution of soluble intercellular adhesion molecule-1 to the migration of vascular smooth muscle cells. Eur J Pharmacol 579 1-3 (2008) 260-268
13. Moon S.K., Kim H.M., Lee Y.C., and Kim C.H. Disialoganglioside (GD3) synthase gene expression suppresses vascular smooth muscle cell responses via the inhibition of ERK1/2 phosphorylation, cell cycle progression, and matrix metalloproteinase-9 expression. J Biol Chem 279 32 (2004) 33063-33070
14. Moon S.K., Cha B.Y., and Kim C.H. ERK1/2 mediates TNF-alpha-induced matrix metalloproteinase-9 expression in human vascular smooth muscle cells via the regulation of NF-kappaB and AP-1: involvement of the ras dependent pathway. J Cell Physiol 198 (2004) 417-427
15. Sato H., and Seiki M. Regulatory mechanism of 92 kDa type IV collagenase gene expression which is associated with invasiveness of tumor cells. Oncogene 8 2 (1993) 395-405
16. Granger J.P., Alexander B.T., Llinas M.T., Bennett W.A., and Khalil R.A. Pathophysiology of hypertension during preeclampsia: linking placental ischemia with endothelial dysfunction. Hypertension 38 (2001) 718-722
17. Conrad K.P., Miles T.M., and Benyo D.F. Circulating levels of immunoreactive cytokines in women with preeclampsia. Am J Reprod Immunol 40 (1998) 102-111
18. Sanz-Rosa D., Oubiña M.P., Cediel E., de Las Heras N., Vegazo O., Jiménez J., et al. Effect of AT1 receptor antagonism on vascular and circulating inflammatory mediators in SHR: role of NF-kappaB/IkappaB system. Am J Physiol Heart Circ Physiol 288 1 (2005) H111-115
19. Cho A., Graves J., and Reidy M.A. Mitogen-activated protein kinases mediate matrix metalloproteinase-9 expression in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 20 (2000) 2527-2532
20. Sherr C.J. G1 phase progression: cycling on cue. Cell 79 (1994) 551-555
21. Sherr C.J. Cancer cell cycles. Science 274 (1996) 1672-1677
22. Ohtsubo M., Theodoras A.M., Schumacher J., Roberts J.M., and Pagano M. Human cyclin E, a nuclear protein essential for the G1-to-S phase transition. Mol Cell Biol 15 (1995) 2612-2624
23. Toyoshima H., and Hunter T. p27, a novel inhibitor of G1 cyclin-cdk protein kinase activity, is related to p21. Cell 78 (1994) 67-74
24. Weiss R.H., Joo A., and Randour C. p21(Waf1/Cip1) is an assembly factor required for platelet-derived growth factor-induced vascular smooth muscle cell proliferation. J Biol Chem 275 (2000) 10285-10290
25. Kubo A., Fukuda N., Teng J., Satoh C., Nakayama M., Kishioka H., et al. Angiotensin II regulates the cell cycle of vascular smooth muscle cells from SHR. Am J Hypertens 13 10 (2000) 1117-1124
26. Rohde L.E., Ducharme A., and Arroyo L.H. Matrix metalloproteinase inhibition attenuates early left ventricular enlargement after experimental myocardial infarction in mice. Circulation 99 (1999) 3063-3070
27. Pfeffer M.A., and Braunwald E. Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications. Circulation 81 (1990) 1161-1172
28. Spinale F.G., Coker M.L., and Krombach S.R. Matrix metalloproteinase inhibition during the development of congestive heart failure: effects on left ventricular dimensions and function. Circ Res 85 (1999) 364-376
29. Bond M., Chase A.J., Baker A.H., and Newby A.C. Inhibition of transcription factor NF-kappaB reduces matrix metalloproteinase-1, -3 and -9 production by vascular smooth muscle cells. Cardiovasc Res 50 3 (2001) 556-565
30. Contard F., Sabri A., Glukhova M., Sartore S., Marotte F., Pomies J.P., et al. Arterial smooth muscle cell phenotype in stroke-prone spontaneously hypertensive rats. Hypertension 22 5 (1993) 665-676
31. Umemoto S., Kawahara S., Hashimoto R., Umeji K., Matsuda S., Tanaka M., et al. Different effects of amlodipine and enalapril on the mitogen-activated protein kinase/extracellular signal-regulated kinase kinase-extracellular signal-regulated kinase pathway for induction of vascular smooth muscle cell differentiation in vivo. Hypertens Res 29 3 (2006) 179-186
32. Li H., Simon H., Bocan T.M., and Peterson J.T. MMP/TIMP expression in spontaneously hypertensive heart failure rats: the effect of ACE- and MMP-inhibition. Cardiovasc Res 46 2 (2000) 298-306